{"cmr":"ca-cm-kg/TSXV/NRX","since":null,"total":10,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-10-30","event_type":"newswire_release","title":"NurExone Demonstrates Consistent Anti-Inflammatory Activity","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/30/3392203/0/en/nurexone-demonstrates-consistent-anti-inflammatory-activity-across-three-separate-batches-of-exosomes.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"03IsEgvGXhcxBsLpEuF_2E5tzL1BILQpAOIyEYnb-0i_JW7ywPRo1Y_fJuTyLwvfI0WU9KV08eHTwXWeW8RFDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-10-22","event_type":"newswire_release","title":"NurExone Demonstrates Scalable Exosome Production,","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/22/3386349/0/en/nurexone-demonstrates-scalable-exosome-production-supporting-its-modular-manufacturing-strategy-and-commercial-growth.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7ddn6iHIrStItZxamRLQMYihg9i_8Thr3ME1hQiYRdnrcJUsBzv4fFT1SnLUnZ1Ec5hq-78SaRKFnj2bUJpbDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-10-09","event_type":"newswire_release","title":"NurExone Advances Optic Nerve Injury Program Toward","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/09/3378353/0/en/nurexone-advances-optic-nerve-injury-program-toward-larger-animal-study-following-positive-preclinical-results.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZkfxNKn6hdaHIYrJpkqNHQ2yCQCLrM3hxLdctc171T1cKDwxEzJXfiRDhhv9F71L9RWd2pjSs6sXi0blCum7AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-09-18","event_type":"newswire_release","title":"NurExone Expands U.S. Engagement Across Four Major Boston","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/18/3364949/0/en/nurexone-expands-u-s-engagement-across-four-major-boston-life-sciences-events-and-provides-corporate-update.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0QWAgFFCBqb4MUYdLeFvaDLWfYpGnTc80fbozUS_2xpU8XOb1a_WVXtU8mfOttM15e_BWp20y4eDKKr-bfaJAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-09-16","event_type":"newswire_release","title":"NurExone Announces Voting Results of Annual General and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/16/3363531/0/en/nurexone-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pjLXvYKoJchSZUcxgkeiiqr4RNPPeMlVHOD0PP1JAdfxGHr0Ye9isEN1luk3B6BpKaVL8FJCia4KZUzS3EKEBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-09-14","event_type":"newswire_release","title":"NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/14/3361533/0/en/nurexone-and-nanopass-technologies-ltd-to-collaborate-on-integrated-exosome-delivery-approach-for-regenerative-eye-and-skin-applications.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'nurexone'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NlcboML-HviXmqfIa5K9TsyroqekPIbhqBRUK0Myt5nSQnNjBxccHp7R832uRDS3qe48d98e2FkdJ37lWf4ODA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-09-09","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321136&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8ZR5tf-s9ga3r32c-Bm-g39fsVL84uIAszxQ_JxlA3p9LiEPWpGNu2X_M0EXk_aMrmPYr8h-CcjHCgxG-rjbAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-08-06","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=320459&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7nVIirrmt9Z2jEFTn1r1fDgiGrHLBn_ngatboKUXt379k1yQjPBl5UBJfkx6uDQNGu-rksxT79JAuEZYC0gxAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2026-04-15","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=316192&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AhnEqCVF9Qq0l4qqO_IytOAdrYfGe9rhHQI1o4M5rgBD5eyBTya6NGWLDt-d5C-upK0BesH2TlFKODlQfD28Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/NRX","date":"2025-09-17","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=302617&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UvyYpvJQFRfaNAsMJ5EV-uWRiOz6tQSPToDgLyTN1_yY4zYEbOSzGntiCVUXxcxi9zemzfkUaR_k0XRQMoHBAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}